These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38749112)

  • 1. Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study.
    Zhi Y; Li S; Li Y; Ren W; Gao L; Zhi K
    Oral Oncol; 2024 Jul; 154():106849. PubMed ID: 38749112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
    Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery.
    Dong L; Xue L; Cheng W; Tang J; Ran J; Li Y
    BMC Oral Health; 2024 Aug; 24(1):919. PubMed ID: 39123139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological safety of submental island flap for reconstruction of pathologically node-negative and node-positive T1-2 oral squamous cell carcinoma-related defects: A retrospective study and comparison of outcomes.
    Wang J; Tan Y; Shen Y; Lv M; Li J; Sun J
    Oral Oncol; 2020 Mar; 102():104507. PubMed ID: 31896500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma.
    Hatano K; Saigo C; Kito Y; Shibata T; Takeuchi T
    Clin Exp Dent Res; 2020 Apr; 6(2):174-180. PubMed ID: 32250571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors of Oral Squamous Cell Carcinoma with Special Emphasis on Areca Nut Usage and Its Association with Clinicopathological Parameters and Recurrence.
    Hashmi AA; Mudassir G; Rashid K; Malik UA; Zia S; Zia F; Irfan M
    Int J Surg Oncol; 2024; 2024():9725822. PubMed ID: 39233744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Factors Are Associated With Regional Recurrence After Operative Treatment of Oral Squamous Cell Carcinoma?
    Troeltzsch M; Haidari S; Boser S; Troeltzsch M; Probst FA; Ehrenfeld M; Otto S
    J Oral Maxillofac Surg; 2018 Dec; 76(12):2650-2659. PubMed ID: 30098956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Different Mandibulectomy (Marginal vs Segmental) Affect the Prognosis in Patients With Oral Squamous Cell Carcinoma?
    Qiu Y; Lin L; Shi B; Zhu X
    J Oral Maxillofac Surg; 2018 May; 76(5):1117-1122. PubMed ID: 29227794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
    Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
    Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.
    Ebrahimi A; Clark JR; Zhang WJ; Elliott MS; Gao K; Milross CG; Shannon KF
    Head Neck; 2011 Sep; 33(9):1245-51. PubMed ID: 20967874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral squamous cell carcinoma: clinicopathological features in patients with and without recurrence.
    Camisasca DR; Silami MA; Honorato J; Dias FL; de Faria PA; Lourenço Sde Q
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):170-6. PubMed ID: 21625192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.
    Grimm M
    Clin Transl Oncol; 2012 Nov; 14(11):870-80. PubMed ID: 22855158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histopathologic parameters in survival of oral squamous cell carcinoma.
    Dissanayaka WL; Pitiyage G; Kumarasiri PV; Liyanage RL; Dias KD; Tilakaratne WM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):518-25. PubMed ID: 22668430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degree of Keratinization Is an Independent Prognostic Factor in Oral Squamous Cell Carcinoma.
    Wolfer S; Elstner S; Schultze-Mosgau S
    J Oral Maxillofac Surg; 2018 Feb; 76(2):444-454. PubMed ID: 28738193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perineural invasion in T1 oral squamous cell carcinoma indicates the need for aggressive elective neck dissection.
    Tai SK; Li WY; Yang MH; Chu PY; Wang YF
    Am J Surg Pathol; 2013 Aug; 37(8):1164-72. PubMed ID: 23681077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of factors associated with the risk stratification of survivorship for stage IV squamous cell carcinoma of the oral cavity: A 10-year retrospective study.
    Cheng HC; Yang CC; Kao SY; Wu TY; Wu CH
    J Chin Med Assoc; 2020 May; 83(5):491-499. PubMed ID: 32132387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features.
    Chang WC; Chang CF; Li YH; Yang CY; Su RY; Lin CK; Chen YW
    Oral Oncol; 2019 Aug; 95():65-73. PubMed ID: 31345396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.